Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin use. It treats superficial fungal infections of the skin and nails by targeting the causative dermatophytes. GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal indicated for several superficial dermatophyte infections. - Tinea pedis (athlete's foot): reduces fungal growth, relieving itching, scaling and redness. - Tinea corporis (ringworm): clears the infection and promotes healing of skin lesions. - Tinea cruris (jock itch): diminishes fungal proliferation and eases discomfort in the groin area. - Tinea versicolor: normalizes skin pigmentation by eliminating the yeast responsible. - Superficial dermatophyte infections: eradicates the causative fungi and restores normal skin integrity.

Lamisil is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Local skin irritation: redness, burning or stinging at the application site. - Pruritus: mild itching of the treated area. - Dryness: skin may become dry or flaky. - Erythema: mild redness without infection. - Contact dermatitis: allergic skin reaction in sensitive individuals.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Hepatotoxicity: signs of liver dysfunction such as jaundice or dark urine. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Blood disorders: unexplained bruising or bleeding. - Persistent irritation: worsening redness or ulceration at the site.

Before using Lamisil, consider the following safety measures. - Allergy assessment: avoid if known hypersensitivity to terbinafine or formulation components. - Liver function: use caution in patients with existing liver disease; monitor hepatic enzymes if prolonged therapy is required. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Pediatric use: limit to ages and conditions approved by local regulatory authorities. - Application area: apply only to intact skin, avoiding eyes, mucous membranes and open wounds. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine may interact with other medications, requiring attention to potential effects.

Major Interactions (Avoid): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase terbinafine plasma levels. - Warfarin: concurrent use may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce terbinafine effectiveness. - Other antifungals (e.g., itraconazole): combined use may increase toxicity. - Alcohol: excessive intake may exacerbate liver strain during therapy.